BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 29149835)

  • 1. Forkhead Transcription Factors: Formulating a FOXO Target for Cognitive Loss.
    Maiese K
    Curr Neurovasc Res; 2017; 14(4):415-420. PubMed ID: 29149835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Treatment Strategies for the Nervous System: Circadian Clock Genes, Non-coding RNAs, and Forkhead Transcription Factors.
    Maiese K
    Curr Neurovasc Res; 2018; 15(1):81-91. PubMed ID: 29557749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forkhead transcription factors: new considerations for alzheimer's disease and dementia.
    Maiese K
    J Transl Sci; 2016 Jul; 2(4):241-247. PubMed ID: 27390624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive Impairment and Dementia: Gaining Insight through Circadian Clock Gene Pathways.
    Maiese K
    Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR.
    Maiese K
    Neural Regen Res; 2016 Mar; 11(3):372-85. PubMed ID: 27127460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospects and Perspectives for WISP1 (CCN4) in Diabetes Mellitus.
    Maiese K
    Curr Neurovasc Res; 2020; 17(3):327-331. PubMed ID: 32216738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FoxO Transcription Factors and Regenerative Pathways in Diabetes Mellitus.
    Maiese K
    Curr Neurovasc Res; 2015; 12(4):404-13. PubMed ID: 26256004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harnessing the Power of SIRT1 and Non-coding RNAs in Vascular Disease.
    Maiese K
    Curr Neurovasc Res; 2017; 14(1):82-88. PubMed ID: 27897112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the core of neurodegeneration: FoxO, mTOR, and SIRT1.
    Maiese K
    Neural Regen Res; 2021 Mar; 16(3):448-455. PubMed ID: 32985464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FoxO proteins in the nervous system.
    Maiese K
    Anal Cell Pathol (Amst); 2015; 2015():569392. PubMed ID: 26171319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of aging and oxidative stress in metabolic and nervous system disorders: programmed cell death and molecular signal transduction crosstalk.
    Maiese K
    Front Immunol; 2023; 14():1273570. PubMed ID: 38022638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirtuins: Developing Innovative Treatments for Aged-Related Memory Loss and Alzheimer's Disease.
    Maiese K
    Curr Neurovasc Res; 2018; 15(4):367-371. PubMed ID: 30484407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Forkhead Transcription Factors of the O Class (FoxO) in Development and Progression of Alzheimer's Disease.
    Goswami S; Kareem O; Goyal RK; Mumtaz SM; Tonk RK; Gupta R; Pottoo FH
    CNS Neurol Disord Drug Targets; 2020; 19(9):709-721. PubMed ID: 33001019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurodegeneration, memory loss, and dementia: the impact of biological clocks and circadian rhythm.
    Maiese K
    Front Biosci (Landmark Ed); 2021 Sep; 26(9):614-627. PubMed ID: 34590471
    [No Abstract]   [Full Text] [Related]  

  • 15. Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer.
    Maiese K
    Curr Neurovasc Res; 2017; 14(3):299-304. PubMed ID: 28721811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive Impairment in Multiple Sclerosis.
    Maiese K
    Bioengineering (Basel); 2023 Jul; 10(7):. PubMed ID: 37508898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The "O" class: crafting clinical care with FoxO transcription factors.
    Maiese K; Chong ZZ; Hou J; Shang YC
    Adv Exp Med Biol; 2009; 665():242-60. PubMed ID: 20429429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotinamide as a Foundation for Treating Neurodegenerative Disease and Metabolic Disorders.
    Maiese K
    Curr Neurovasc Res; 2021; 18(1):134-149. PubMed ID: 33397266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive impairment with diabetes mellitus and metabolic disease: innovative insights with the mechanistic target of rapamycin and circadian clock gene pathways.
    Maiese K
    Expert Rev Clin Pharmacol; 2020 Jan; 13(1):23-34. PubMed ID: 31794280
    [No Abstract]   [Full Text] [Related]  

  • 20. Regeneration in the nervous system with erythropoietin.
    Maiese K
    Front Biosci (Landmark Ed); 2016 Jan; 21(3):561-596. PubMed ID: 26549969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.